郭莉

【摘 要】 目的：分析阿司匹林结合阿托伐他汀钙治疗神经内科中脑血栓患者的临床效果。方法：选取我院2016年06月～2018年06月间收治50例神经内科脑血栓患者，采用随机摸球法将患者分為观察组（25例）和对照组（25例），对照组采用阿司匹林治疗，观察组在对照组的基础上采用阿托伐他汀钙治疗，比较两组患者血脂指标。结果：治疗前两组患者血液治疗差异无统计学意义（p>0.05），观察组血液指标明显优于对照组，差异具有统计学意义（P<0.05）。结论：神经内科脑血栓患者采用阿司匹林联合阿托伐他汀钙治疗，可有效改善血脂指标，具有一定临床价值，值得推广应用。

【关键词】 阿司匹林;阿托伐他汀钙;神经内科;脑血栓

【中图分类号】R743.3【文献标志码】B【文章编号】1005-0019（2019）09-024-01

Abstract Objective： To analyze the clinical effect of aspirin combined with atorvastatin calcium in the treatment of middle cerebral thrombosis in neurology department. Methods：50 patients with cerebral thrombosis in neurology department were selected in our hospital from June 2016 to June 2018. The patients were divided into observation group （25 cases） and control group （25 cases） by random touching. The control group was treated with aspirin， while the observation group was treated with atorvastatin calcium on the basis of the control group. The blood lipid indexes of the two groups were compared. Result： There was no significant difference in blood treatment between the two groups before treatment （p > 0.05）. The blood index of the observation group was significantly better than that of the control group， and the difference was statistically significant （P < 0.05）. CONCLUSION： Aspirin combined with atorvastatin calcium can effectively improve blood lipid index in patients with cerebral thrombosis in neurology department， which has certain clinical value and is worth popularizing and applying.

Key words：

aspirin; atorvastatin calcium; neurology; cerebral thrombosis

脑血栓是临床常见的神经内科疾病，高发于老年人群。随着我国老龄化日益加深，脑血栓发病率逐年递增。相关研究显示，脑血栓死亡率高达25%[1]。不仅严重影响患者的正常生活，也给患者带来一定痛苦。本文重点分析阿司匹林结合阿托伐他汀钙治疗神经内科中脑血栓患者的临床效果，现有如下报道：

1 资料和方法

1.1 一般资料

选取我院2016年06月～2018年06月间收治50例神经内科脑血栓患者，采用随机摸球法将患者分为观察组（25例）和对照组（25例），对照组男性12例，女性13例，年龄55-70岁，平均年龄（62.12+5.34）岁，观察组男性14例，的女性11例，年龄60-75岁，平均年龄（67.21+5.12）岁，比较两组患者一般资料，差异无统计学意义（p>0.05）。

纳入标准：（1）所有患者均符合神经内科脑血栓相关临床诊断标准;（2）患者精神意识正常;（3）患者均签署知情同意书。

排除标准：（1）患者患有严重肝肾障碍;（2）患者患有恶性肿瘤等疾病;（3）患者依从性差，拒绝配合治疗。